These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24934532)

  • 1. [Serotonin hypothesis and pulmonary artery hypertension].
    Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H
    Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and pulmonary hypertension--from bench to bedside?
    MacLean MR; Dempsie Y
    Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
    White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
    Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension: therapeutic targets within the serotonin system.
    Dempsie Y; MacLean MR
    Br J Pharmacol; 2008 Oct; 155(4):455-62. PubMed ID: 18536742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin Signaling Through the 5-HT
    Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
    MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA
    Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.
    Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM
    Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
    Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
    J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension and the serotonin hypothesis: where are we now?
    MacLean MR
    Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease.
    Lawrie A; Spiekerkoetter E; Martinez EC; Ambartsumian N; Sheward WJ; MacLean MR; Harmar AJ; Schmidt AM; Lukanidin E; Rabinovitch M
    Circ Res; 2005 Aug; 97(3):227-35. PubMed ID: 16002749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
    Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S
    Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters.
    Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F
    Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin hypothesis of pulmonary hypertension revisited.
    Maclean MR; Dempsie Y
    Adv Exp Med Biol; 2010; 661():309-22. PubMed ID: 20204739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.
    Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR
    Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
    Liu Y; Suzuki YJ; Day RM; Fanburg BL
    Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).
    MacLean MMR
    Pulm Circ; 2018; 8(2):2045894018759125. PubMed ID: 29468941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
    Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
    Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
    Wang HL
    Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen receptor alpha in pulmonary hypertension.
    Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
    Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cells.
    Baskar K; Sur S; Selvaraj V; Agrawal DK
    Mol Biol Rep; 2015 Aug; 42(8):1295-307. PubMed ID: 25861735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.